SBIO Holdings Information

SBIO is an equity ETF with a total of 90 individual holdings. The top holdings are Kymera Therapeutics stock at 4.03%, Alkermes at 3.73%, Mirum Pharmaceuticals at 3.39%, Celcuity at 3.24%, and Structure Therapeutics at 2.99%.

Total Holdings

Top 10 Percentage

30.99%

Asset Class

Equity

ETF Category

Health

Assets

135.92M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	KYMR	Kymera Therapeutics, Inc.	4.03%	68,917
2	ALKS	Alkermes plc	3.73%	144,127
3	MIRM	Mirum Pharmaceuticals, Inc.	3.39%	44,831
4	CELC	Celcuity Inc.	3.24%	40,376
5	GPCR	Structure Therapeutics Inc.	2.99%	53,022
6	FOLD	Amicus Therapeutics, Inc.	2.96%	269,358
7	CRNX	Crinetics Pharmaceuticals, Inc.	2.86%	82,845
8	CGON	CG Oncology, Inc.	2.67%	70,415
9	ACAD	ACADIA Pharmaceuticals Inc.	2.67%	147,665
10	NAMS	NewAmsterdam Pharma Company N.V.	2.45%	98,998
11	APGE	Apogee Therapeutics, Inc.	2.29%	47,930
12	XENE	Xenon Pharmaceuticals Inc.	2.10%	67,414
13	VKTX	Viking Therapeutics, Inc.	2.00%	98,694
14	IRON	Disc Medicine, Inc.	1.99%	32,966
15	DNLI	Denali Therapeutics Inc.	1.98%	128,373
16	EWTX	Edgewise Therapeutics, Inc.	1.94%	92,453
17	APLS	Apellis Pharmaceuticals, Inc.	1.92%	110,439
18	IDYA	IDEAYA Biosciences, Inc.	1.87%	76,515
19	TVTX	Travere Therapeutics, Inc.	1.77%	78,079
20	TARS	Tarsus Pharmaceuticals, Inc.	1.77%	37,051
21	VERA	Vera Therapeutics, Inc.	1.76%	55,844
22	SYRE	Spyre Therapeutics, Inc.	1.72%	67,736
23	MLYS	Mineralys Therapeutics, Inc.	1.50%	69,093
24	GLPG	Galapagos NV	1.47%	57,221
25	MAZE	Maze Therapeutics, Inc.	1.42%	41,988

Showing 25 of 90 holdings

Subscribe to see the full list

Activate Now

As of Feb 5, 2026